Clinical Trial Detail

NCT ID NCT02052778
Title A Study of TAS-120 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

glioblastoma multiforme

Advanced Solid Tumor

oligodendroglioma

transitional cell carcinoma

cholangiocarcinoma

grade III astrocytoma

Therapies

Futibatinib

Age Groups: senior adult

Additional content available in CKB BOOST